Myasthenia gravis trials in Türkiye

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

  Where

  Ankara, Atakum/SAMSUN, Istanbul, Izmir, Kocaeli, Mersin, Trabzon

  Age

  18 years and over

  People

  264 worldwide

  Run by

  Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

  See details and how to joinNCT06463587 · EU 2023-507746-83-00